Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07132255) titled 'The Efficacy and Safety Evaluation of 5G Tele-PCI Using R-OneTM' on Aug. 11.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Cathbot (Shanghai) Robot Co., Ltd
Condition:
Coronary Artery Disease (CAD)
Percutaneous Coronary Intervention (PCI)
Intervention:
Device: R-One assisted tele-PCI
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: March 14, 2024
Target Sample Size: 60
Countries of Recruitment:
China
To know more, visit https://clinicaltrials.gov/ct2/s...